Research News

OCRFA applauds FDA’s statement on ovarian cancer screening test

On September 7th, the FDA issued an important safety communication about tests marketed as ovarian cancer screening tests, including the ROCA Test developed by Abcodia Incorporated…

Read on

Risk-reducing Oophorectomy is Risky, Study Shows

A Mayo Clinic research team has found evidence suggesting that premenopausal women who are not at high risk of ovarian cancer should not have their ovaries removed for the purpose of cancer prevention…

Read on

Niraparib Significantly Improves Outcome of Ovarian Cancer Patients

(October 11, 2016) According to research published this month in the New England Journal of Medicine, the PARP inhibitor niraparib improves progression free survival in recurrent, platinum-sensitive women both with and without germline BRCA…

Read on

Meet Researcher Dr. Hui Shen

Meet a Researcher: We had the chance to interview Dr. Hui Shen, a 2016 Liz Tilberis Early Career Award grantee to get to know her! Read our interview here. OCRFA: Tell us about yourself. Dr. Hui Shen: My name is Hui Shen…

Read on

Stand Up to Cancer Update Webinar

OCRFA and Dr. Elizabeth Swisher spoke about the exciting progress being made by the Stand Up to Cancer Ovarian Cancer Dream Team! The SU2C Ovarian Cancer Dream Team, funded by OCRFA and NOCC, got to work on year ago. Dr…

Read on

Low Volume Surgeons Lead to Poorer Outcomes

(October 5, 2016) A new analysis published in the American Journal of Obstetrics and Gynecology determined the impact of gynecologic surgeon volumes on patient outcomes…

Read on

OCRFA Research Shows Drugs Help Anti-Tumor Immunity

(October 5, 2016) A team of researchers, including senior author and former OCRFA grantee Rugang Zhang, PhD, have been studying the relationship between PD-1 and PD-L1, a protein and an accompanying molecule, and t-cells, which are a body’s…

Read on

Report from the Biennial Ovarian Cancer Research Symposium

Research Advocate, Annie Ellis, recently attended the Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research…

Read on

Update on ROCA Test

On September 13th, Abcodia Incorporated, the makers of the ROCA Test, released this statement*, following the safety guidance put out by the FDA last week. ROCA Test sales are now suspended in the United States…

Read on

#30DaysofTeal: Day 5

Meet Researcher Kris Wood, PhD! Q&A with Kris Wood, PhD Duke University 2015 Liz Tilberis Award OCRFA: Tell me about yourself. Kris Wood: I grew up in Georgetown, KY, a rural town in the central part of the state…

Read on

SGO and ASCO Agree on Guidelines for Common Type of Ovarian Cancer

(August 16, 2016) While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some patients may benefit more from…

Read on

Impact of Genetic Counseling on Testing and Surgical Prevention in High Risk Women

(Aug 1. 2016) Results of a study reported last month in Cancer show that routine referral of women at high risk for ovarian cancer to genetic counseling promotes genetic testing and prophylactic surgery…

Read on
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]